Brief: Tianjin Teda Biomedical Engineering Co says qtrly revenue from cont ops RMB90.9 million
09/11/2017 11:35
Nov 9 (Reuters) - Tianjin Teda Biomedical Engineering Co Ltd
8189.HK :
* Qtrly revenue from continuing operations RMB90.9 million
versus
RMB92.7 million
* Qtrly loss attributable from continuing operations RMB7.1
million versus profit of RMB3.6 mln
Source text for Eikon: ID:nHKS2CY6vV
Further company coverage: 8189.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Tianjin Teda Biomedical Engineering Co
See all newsBrief: Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO
Brief: Tianjin Teda Biomedical Engineering Signs AI Healthcare Cooperation Agreement
Brief: Tianjin Teda Biomedical Engineering Says Unit Enters Strategic Cooperation
Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
Brief: Tianjin Teda Biomedical Engineering Says Re-Designation Of He Xin To Non-Executive Director